(Bloomberg) When Elliott Investment Management came calling for the ouster of Emma Walmsley, the chief executive officer of GSK Plc found her remedy in a product almost 60 years in the making.Most Read from BloombergHims Debuts $199 Weight-Loss Shots at 85% Discount to WegovyIran State TV Says ‘No Sign of Life’ at Helicopter Crash SiteJamie Dimon Says Succession at JPMorgan Is ‘Well on the Way’One of the Last Big Bears on Wall Street Turns Bullish on US StocksFlorida’s 125% Surge in Property-
United-kingdom
London
City-of
Stevenage
Hertfordshire
Britain
Alex-chajecki
Philip-hampton
Jon-symonds
Swetha-gopinath
Emma-walmsley
Alisa-pham
GSK's SWIFT trials show long-acting treatment reduces attacks
fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.
Emma-walmsleyKaivan-khavandiHow GSK CEO Emma Walmsley kept her job and turned a belligerent activist investor into an ally
biztoc.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biztoc.com Daily Mail and Mail on Sunday newspapers.
United-kingdomBritainEmma-walmsleyElliott-investment-management